Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 118

    1.

    Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.

    Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H; DNETT-Japan Study Group.

    Diabetes Res Clin Pract. 2009 Nov 2. [Epub ahead of print]PMID: 19889469 [PubMed - as supplied by publisher]Related articles

    2.

    Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.

    Araki S, Matsuno H, Haneda M, Koya D, Kanno Y, Itho J, Kishi A, Isshiki K, Sugimoto T, Maegawa H, Kashiwagi A, Uzu T.

    Diabetes Care. 2009 Nov;32(11):2062-7. Epub 2009 Aug 12.PMID: 19675198 [PubMed - in process]Related articles

    3.

    Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial.

    Koya D, Haneda M, Inomata S, Suzuki Y, Suzuki D, Makino H, Shikata K, Murakami Y, Tomino Y, Yamada K, Araki SI, Kashiwagi A, Kikkawa R; Low-Protein Diet Study Group.

    Diabetologia. 2009 Oct;52(10):2037-45. Epub 2009 Aug 4.PMID: 19652945 [PubMed - in process]Related articlesFree article

    4.

    Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia.

    Ugi S, Shi K, Nishio Y, Shimizu S, Guo B, Sekine O, Ikeda K, Egawa K, Yoshizaki T, Nagai Y, Koya D, Takada T, Torii R, Kimura H, Kashiwagi A, Maegawa H.

    J Biochem. 2009 Oct;146(4):541-7. Epub 2009 Jul 15.PMID: 19605464 [PubMed - in process]Related articles

    5.

    Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects.

    Konishi K, Nakano S, Seto H, Tsuda S, Koya D.

    Diabetes Res Clin Pract. 2009 Aug;85(2):171-8. Epub 2009 May 30.PMID: 19482369 [PubMed - indexed for MEDLINE]Related articles

    6.

    SIRT1 and insulin resistance.

    Liang F, Kume S, Koya D.

    Nat Rev Endocrinol. 2009 Jul;5(7):367-73. Epub 2009 May 19. Review.PMID: 19455179 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.

    Uzu T, Sakaguchi M, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A.

    Clin Exp Nephrol. 2009 Aug;13(4):300-6. Epub 2009 Mar 3. Erratum in: Clin Exp Nephrol. 2009 Aug;13(4):307. PMID: 19255824 [PubMed - indexed for MEDLINE]Related articles

    8.

    Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model.

    Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, Sugimoto T, Nishiyama A, Koya D, Haneda M, Kashiwagi A, Uzu T.

    Biochem Biophys Res Commun. 2009 Feb 27;380(1):44-9. Epub 2009 Jan 14.PMID: 19150338 [PubMed - indexed for MEDLINE]Related articles

    9.

    Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.

    Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T.

    Endocrinology. 2009 Apr;150(4):1662-9. Epub 2008 Dec 18.PMID: 19095745 [PubMed - indexed for MEDLINE]Related articles

    10.

    Structural and functional changes in the kidneys of high-fat diet-induced obese mice.

    Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T.

    Am J Physiol Renal Physiol. 2009 Jan;296(1):F118-26. Epub 2008 Oct 29.PMID: 18971213 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.

    Araki S, Haneda M, Koya D, Kashiwagi A, Uzu T, Kikkawa R.

    Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S54-8. Epub 2008 Oct 22. Review.PMID: 18947896 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impedance detected abnormal bolus transit in patients with normal esophageal manometry. Sensitive indicator of esophageal functional abnormality?

    Koya DL, Agrawal A, Freeman JE, Castell DO.

    Dis Esophagus. 2008;21(6):563-9. Epub 2008 Jun 28.PMID: 18564161 [PubMed - indexed for MEDLINE]Related articles

    13.

    AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects.

    Konishi K, Nakano S, Tsuda S, Nakagawa A, Kigoshi T, Koya D.

    Diabetes Res Clin Pract. 2008 Sep;81(3):310-5. Epub 2008 Jun 11.PMID: 18550198 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.

    Koya DL, Hill EG, Darden PM.

    Am J Public Health. 2008 May;98(5):832-8. Epub 2008 Apr 1.PMID: 18382000 [PubMed - indexed for MEDLINE]Related articles

    15.

    Asialoerythropoietin prevents contrast-induced nephropathy.

    Yokomaku Y, Sugimoto T, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Nitta N, Haneda M, Koya D, Uzu T, Kashiwagi A.

    J Am Soc Nephrol. 2008 Feb;19(2):321-8. Epub 2008 Jan 9.PMID: 18184858 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Peroxisome proliferator-activated receptors in diabetic nephropathy.

    Kume S, Uzu T, Isshiki K, Koya D.

    PPAR Res. 2008;2008:879523. Epub 2009 Mar 4.PMID: 19277201 [PubMed - in process]Related articlesFree article

    17.

    A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.

    Tsuda S, Nakano S, Konishi K, Koya D.

    Diabetes Res Clin Pract. 2008 Mar;79(3):503-9. Epub 2007 Nov 19.PMID: 18006102 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acute nephritic syndrome and polymyalgia rheumatica: coincidental or associated?

    Sugimoto T, Tanaka Y, Kanasaki K, Isshiki K, Takashi U, Koya D, Kashiwagi A.

    Nephrology (Carlton). 2007 Dec;12(6):625. No abstract available. PMID: 17995594 [PubMed - indexed for MEDLINE]Related articles

    19.

    Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet.

    Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D.

    J Am Soc Nephrol. 2007 Oct;18(10):2715-23. Epub 2007 Sep 12.PMID: 17855643 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Molecular understanding of adverse effects of hyperglycemia in diabetic nephropathy]

    Koya D.

    Nippon Jinzo Gakkai Shi. 2007;49(5):470-3. Review. Japanese. No abstract available. PMID: 17695806 [PubMed - indexed for MEDLINE]Related articles

    21.

    Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants.

    Koya DL, Egede LE.

    J Gen Intern Med. 2007 Jun;22(6):841-6. Epub 2007 Mar 9.PMID: 17503110 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.

    Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

    Diabetes. 2007 Jun;56(6):1727-30. Epub 2007 Mar 14.PMID: 17360976 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells.

    Morita Y, Araki H, Sugimoto T, Takeuchi K, Yamane T, Maeda T, Yamamoto Y, Nishi K, Asano M, Shirahama-Noda K, Nishimura M, Uzu T, Hara-Nishimura I, Koya D, Kashiwagi A, Ohkubo I.

    FEBS Lett. 2007 Apr 3;581(7):1417-24. Epub 2007 Mar 5. Erratum in: FEBS Lett. 2007 Jul 24;581(18):3579. PMID: 17350006 [PubMed - indexed for MEDLINE]Related articles

    24.

    Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.

    Araki S, Haneda M, Koya D, Sugimoto T, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

    Diabetologia. 2007 Apr;50(4):867-73. Epub 2007 Jan 16.PMID: 17225121 [PubMed - indexed for MEDLINE]Related articles

    25.

    Pulmonary-renal syndrome, diffuse pulmonary hemorrhage and glomerulonephritis, associated with Wegener's granulomatosis effectively treated with early plasma exchange therapy.

    Sugimoto T, Deji N, Kume S, Osawa N, Sakaguchi M, Isshiki K, Koya D, Kashiwagi A.

    Intern Med. 2007;46(1):49-53. Epub 2007 Jan 1.PMID: 17202734 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy.

    Osawa N, Koya D, Araki S, Uzu T, Tsunoda T, Kashiwagi A, Nakamura Y, Maeda S.

    J Hum Genet. 2007;52(2):143-51. Epub 2006 Dec 2.PMID: 17143591 [PubMed - indexed for MEDLINE]Related articles

    27.

    Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases.

    Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A.

    Nephron Clin Pract. 2007;105(2):c54-7. Epub 2006 Nov 29.PMID: 17135768 [PubMed - indexed for MEDLINE]Related articles

    28.

    SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation.

    Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isshiki K, Isono M, Uzu T, Guarente L, Kashiwagi A, Koya D.

    J Biol Chem. 2007 Jan 5;282(1):151-8. Epub 2006 Nov 10.PMID: 17098745 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Levofloxacin-induced Achilles tendon rupture in a patient with systemic microscopic polyangiitis.

    Sugimoto T, Kaneko H, Deji N, Koya D.

    Mod Rheumatol. 2005;15(3):217-9.PMID: 17029067 [PubMed]Related articles

    30.

    Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension.

    Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Nishio Y, Maegawa H, Koya D, Haneda M, Kashiwagi A.

    J Hypertens. 2006 Aug;24(8):1627-32.PMID: 16877966 [PubMed - indexed for MEDLINE]Related articles

    31.

    Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.

    Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D.

    Free Radic Biol Med. 2006 Jun 15;40(12):2175-82. Epub 2006 Mar 20.PMID: 16785031 [PubMed - indexed for MEDLINE]Related articles

    32.

    Systemic cholesterol embolization syndrome associated with myeloperoxidase-anti-neutrophil cytoplasmic antibody.

    Sugimoto T, Morita Y, Yokomaku Y, Isshiki K, Kanasaki K, Eguchi Y, Koya D, Kashiwagi A.

    Intern Med. 2006;45(8):557-61. Epub 2006 May 15.PMID: 16702752 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Effect of protein kinase Cbeta inhibitor on Ca2+ homeostasis in diabetic sensory neurons.

    Tahara M, Omatsu-Kanbe M, Sanada M, Maeda K, Koya D, Matsuura H, Kashiwagi A, Yasuda H.

    Neuroreport. 2006 Apr 24;17(6):683-8.PMID: 16603936 [PubMed - indexed for MEDLINE]Related articles

    34.

    Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.

    Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D.

    Diabetes Care. 2006 Apr;29(4):864-8.PMID: 16567829 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators.

    Kanasaki K, Haneda M, Sugimoto T, Shibuya K, Isono M, Isshiki K, Araki S, Uzu T, Kashiwagi A, Koya D.

    Biochem Biophys Res Commun. 2006 Apr 14;342(3):758-65. Epub 2006 Feb 17.PMID: 16497271 [PubMed - indexed for MEDLINE]Related articles

    36.

    N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.

    Omata M, Taniguchi H, Koya D, Kanasaki K, Sho R, Kato Y, Kojima R, Haneda M, Inomata N.

    J Am Soc Nephrol. 2006 Mar;17(3):674-85. Epub 2006 Feb 1.PMID: 16452498 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.

    Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A.

    Biochem Biophys Res Commun. 2006 Feb 3;340(1):296-301. Epub 2005 Dec 12.PMID: 16364254 [PubMed - indexed for MEDLINE]Related articles

    38.

    Lupus vasculopathy combined with renal infarction: unusual manifestation of lupus nephritis.

    Sugimoto T, Kanasaki K, Morita Y, Yokomaku Y, Narita M, Koyama T, Tanaka Y, Kashiwagi A, Koya D.

    Intern Med. 2005 Nov;44(11):1185-90.PMID: 16357459 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    A case of myeloperoxidase-antineutrophil cytoplasmic antibody positive-polyarteritis nodosa complicated by interstitial pneumonia and rapidly progressive renal failure.

    Sugimoto T, Kanasaki K, Koyama T, Yokomaku Y, Yasuda H, Kashiwagi A, Koya D.

    Clin Rheumatol. 2007 Mar;26(3):429-32. Epub 2005 Dec 7.PMID: 16333560 [PubMed - indexed for MEDLINE]Related articles

    40.

    Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes.

    Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D.

    Diabetes. 2005 Oct;54(10):2983-7.PMID: 16186402 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Supplement of tetrahydrobiopterin by a gene transfer of GTP cyclohydrolase I cDNA improves vascular dysfunction in insulin-resistant rats.

    Shinozaki K, Nishio Y, Yoshida Y, Koya D, Ayajiki K, Masada M, Kashiwagi A, Okamura T.

    J Cardiovasc Pharmacol. 2005 Oct;46(4):505-12.PMID: 16160605 [PubMed - indexed for MEDLINE]Related articles

    42.

    Familial pseudohyperkalemia: a rare cause of hyperkalemia.

    Sugimoto T, Kume S, Osawa N, Nakazawa J, Koya D, Kashiwagi A.

    Intern Med. 2005 Aug;44(8):875-8.PMID: 16157991 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.

    Guo B, Inoki K, Isono M, Mori H, Kanasaki K, Sugimoto T, Akiba S, Sato T, Yang B, Kikkawa R, Kashiwagi A, Haneda M, Koya D.

    Kidney Int. 2005 Sep;68(3):972-84.PMID: 16105028 [PubMed - indexed for MEDLINE]Related articles

    44.

    [Progress on the drug therapy for diabetic microangiopathies: PKCbeta inhibitor]

    Koya D, Kashiwagi A.

    Nippon Rinsho. 2005 Jun;63 Suppl 6:139-43. Review. Japanese. No abstract available. PMID: 15999697 [PubMed - indexed for MEDLINE]Related articles

    45.

    [Case of autosomal dominant polycystic kidney disease associated with congenital hepatic fibrosis]

    Sugimoto T, Kume S, Osawa N, Isshiki K, Kanasaki K, Tanaka Y, Chin M, Shibuya K, Sakaguchi M, Araki S, Isono M, Koya D.

    Nippon Jinzo Gakkai Shi. 2005;47(4):463-7. Japanese. PMID: 15971890 [PubMed - indexed for MEDLINE]Related articles

    46.

    Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus.

    Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, Koya D, Maegawa H, Kashiwagi A, Babazono T, Matsuda M, Tanaka Y, Fujioka T, Hirose H, Eguchi T, Ohno Y, Groves CJ, Hattersley AT, Hitman GA, Walker M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Kamatani N, McCarthy MI, Nakamura Y.

    J Hum Genet. 2005;50(6):283-92. Epub 2005 Jun 7.PMID: 15940393 [PubMed - indexed for MEDLINE]Related articles

    47.

    Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice.

    Chin M, Isono M, Isshiki K, Araki S, Sugimoto T, Guo B, Sato H, Haneda M, Kashiwagi A, Koya D.

    Am J Pathol. 2005 Jun;166(6):1629-36.PMID: 15920148 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.

    Shimazaki A, Kawamura Y, Kanazawa A, Sekine A, Saito S, Tsunoda T, Koya D, Babazono T, Tanaka Y, Matsuda M, Kawai K, Iiizumi T, Imanishi M, Shinosaki T, Yanagimoto T, Ikeda M, Omachi S, Kashiwagi A, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakajima M, Nakamura Y, Maeda S.

    Diabetes. 2005 Apr;54(4):1171-8.PMID: 15793258 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    [Diabetic nephropathy]

    Koya D, Kashiwagi A.

    Nippon Rinsho. 2005 Feb;63 Suppl 2:625-9. Review. Japanese. No abstract available. PMID: 15779451 [PubMed - indexed for MEDLINE]Related articles

    50.

    N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.

    Shibuya K, Kanasaki K, Isono M, Sato H, Omata M, Sugimoto T, Araki S, Isshiki K, Kashiwagi A, Haneda M, Koya D.

    Diabetes. 2005 Mar;54(3):838-45.PMID: 15734863 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...